Literature DB >> 3317603

The role of extracellular bactericidal factors in pulmonary host defense.

J D Coonrod1.   

Abstract

Extracellular killing provides an attractive hypothesis to explain the rapid alveolar killing of inhaled bacterial pathogens in the absence of conventional opsonins for phagocytosis. Some evidence of extracellular killing of inhaled pneumococci has been obtained using histologic studies and bronchoalveolar lavage. Although studies of the antimicrobial activity of lung lavage fluid in vitro have given variable results, a variety of antimicrobial factors have been detected in lung lavage fluids. Studies of lysozyme, peptides, iron binding proteins, free fatty acids and other factors that are found free in lung lavage fluid indicate that some of these factors could be a part of extracellular pulmonary host defenses. However, their precise role is not known. A survey of mechanisms of extracellular killing shows that granulocytes, monocytes, macrophages, and T lymphocytes all have the capacity to kill extracellularly in vitro in some circumstances. It remains to be determined which of these diverse mechanisms operate within the lung and how they function in relationship to other host defenses.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3317603

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  3 in total

1.  Impaired antipneumococcal activity of bronchoalveolar lining material of neonatal rats.

Authors:  J D Coonrod; M C Jarrells
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

2.  Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon gamma-activated human monocytes depending upon its degree of iron saturation. Iron-lactoferrin and nonphysiologic iron chelates reverse monocyte activation against Legionella pneumophila.

Authors:  T F Byrd; M A Horwitz
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

3.  Application of mathematical model to multiple-dose experimental chemotherapy for fatal murine pneumonia.

Authors:  T Hishikawa; T Kusunoki; K Tsuchiya; Y Uzuka; T Sakamoto; T Nagatake; K Matsumoto
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.